Monday 18 July 2016

Apheresis Market (Therapeutic Apheresis & Donor Apheresis) - Global Forecast 2018

Apheresis, also called as hemapheresis and pheresis is a procedure which involves withdrawal of blood from a donor and separation and retention of its components such as plasma, platelets, leukocytes, and others. Thereafter, the remaining components are transfused back into the donor. 

Thus therapeutic apheresis is a procedure of separation of blood into its components and also includes removal of abnormal components. The overall apheresis market is classified from the perspective of donor apheresis and therapeutic apheresis. 


Increase in health awareness, development in healthcare services in the emerging economies, and an increase in the life expectancy in the developed nations are the major drivers contributing to the growth of the apheresis market worldwide. On the other hand, lack of development of inexpensive apheresis treatment, especially in the economically backward countries, might hamper the growth of this market to some extent. 

The major types of apheresis procedures are plasmapheresis i.e. plasma exchange, leukapheresis, plateletpheresis or thrombocytapheresis, erythrocytapheresis and LDL apheresis. Therapeutic apheresis is a measure used as a last resort when conventional pharmacological treatments turn out to be unsuccessful in controlling incapacitating and chronic medical conditions. 

The major medical domains in which apheresis procedures are conducted are hematology, oncology, neurology, and renal diseases. The major diseases in these categories are leukemia, myasthenia gravis, refractory rheumatoid arthritis, systemic lupus erythematosus, thrombocytosis, polyneuropathy, Guillan Barre syndrome, and sickle cell diseases. The prime technologies employed in apheresis equipment are centrifugation and membrane filtration. The apheresis equipment market can be further categorized into apheresis machines market and disposables market. 

Geographically, the global apheresis market is classified into North America, Europe, Asia Pacific, and Rest of the World. At present the major market share of the global market is enjoyed by North America followed by Europe. The prime players in the apheresis market are Terumo BCT, Fenwal, Inc., Haemonetics Corp., Therakos, Inc. among others. 

No comments:

Post a Comment

Did you like blog? Share your thoughts -